Oncotarget: The Holy Grail of Scientists

For years, scientists have engaged in different research, and now they have a Journal that they can publish their reports. Oncotarget, established in 2010 is a peer-review based journal that is published by the Impact Journal. The editors-in-chief are Andrei V.Gudkov and Mikhail Blagosklonny. Follow Oncotarget on Twitter.

The journal has gained popularity because of its insightful and constructive research publications. The primary goal of the journal is to help the scientists and authors to increase the impact of their research. The journal is licensed under Creative Commons Attribution 3.0 License

The members of the Editorial are experienced and well knowledgeable on the medical research. The editors include Carlo M. Croce and Andrew Schally, a Nobel Prize Winner. The duo has published cumulatively 37 papers on Oncotarget.

Since its inception, four members of the Oncotarget namely Bert Vogelstein, Alexander Varshavsky, Michael N. Hall, and Stephen J. Elledge won the breakthrough prize.

Oncotarget is an open access journal, and regular users of the journal can find new articles every week.

Editorial regulations

Oncotarget primarily publishes research papers on cancer and oncology. However, they also publish articles on the human organism, age-related diseases, immunology, pathology, and physiology.

There are regulations in place to guide the publications. If you publish a paper that is not related to oncology, then you must indicate the appropriate section.

The word limit is 800 words and seven references for the editorial news. The paper should not have more than three co-authors. There is no page or reference limit when it comes to the research papers.

The journal has a publication fee $3,400 for the research papers, reviews, and the case report. There is a reduced fee of $1900 which applies to the research perspectives. As of February 5, 2017, the publication fee is $2,850.

Keep in mind that there is no refund once the first manuscript is published.

Despite the massive criticism of the journal review process, Oncotarget has a 2015 Impact Factor of 5.008 according to the Journal Citation Report. The Impact Factor is a measure that reflects the average citations on the articles published in the Journal. Download output styles at Endnote.com